Home > Insider Trading > Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. (VNDA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 46

Assessing Raptor Pharmaceutical Corp. (RPTP)'s Agreement With HealthCare Royalty Partners

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners. On the face, this deal looks good for shareholders injecting much needed capital into the company.

Keep Reading →

June 17th, 2013 - News

Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks

Perhaps the most famous insider trading involves Martha Stewart who was sentenced to five months in the pen for selling shares in ImClone Systems, allegedly on a tip from her stock broker who figured ...

Keep Reading →

June 17th, 2013 - News

Hedge Funds Have Bought Lamar Advertising Co (LAMR), ITT Educational Services, Inc. (ESI) & More

The most comprehensive picture of hedge fund activity comes in the form of quarterly 13F filings.

Keep Reading →

June 13th, 2013 - Hedge Funds

Baker Bros. Advisors Boosts Stake in Vanda Pharmaceuticals Inc. (VNDA)

In the hedge fund world, Julian Baker and Felix Baker’s Baker Bros. Advisors reported a purchase of 2,028,789 shares in Vanda Pharmaceuticals Inc.

Keep Reading →

June 11th, 2013 - Hedge Funds

This Metric Says You Are Smart to Buy Vanda Pharmaceuticals Inc. (VNDA)

In the 21st century investor’s toolkit, there are many indicators shareholders can use to watch the equity markets. Two of the most underrated are hedge fund and insider trading interest.

Keep Reading →

May 30th, 2013 - News